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Expression of recombinant human 
lysozyme in transgenic chicken promotes 
the growth of Bifidobacterium in the intestine 
and improves postnatal growth of chicken
Hai Wang†, Hongping Wu†, Kejun Wang, Zhichen Cao, Kun Yu, Ling Lian and Zhengxing Lian*
Abstract 
Lysozyme is one kind of antimicrobial proteins and often used as feed additive which can defend against pathogenic 
bacteria and enhance immune function of animals. In this study, we have injected the lentiviral vector expressing 
recombinant human lysozyme (rhLZ) gene into the blastoderm of chicken embryo to investigate the effect of recom-
binant human lysozyme on postnatal intestinal microbiota distribution and growth performance of chicken. Success-
fully, we generated 194 transgenic chickens identified by Southern blot with a positive transgenic rate of 24%. The 
average concentration of rhLZ was 29.90 ± 6.50 μg/mL in the egg white. Lysozyme in egg white of transgenic chick-
ens had a significantly higher antibacterial activity than those of non-transgenic chickens by lysoplate assay (P < 0.05). 
The feces of transgenic and non-transgenic chickens were collected and five types of bacteria (Lactobacillus, Salmo-
nella, Bifidobacterium, Staphylococcus aureus and Escherichia coli) were isolated and cultured to detect the impact of 
rhLZ on gut microbiota. Among the five bacteria, the number of Bifidobacterium in the intestine of those transgenic 
was significantly increased (P < 0.05). Moreover, the growth traits of the transgenic and non-transgenic chickens were 
analyzed. It was found that the 6-week shank length, 6-week weight and 18-week weight of transgenic chickens were 
significantly increased than that of non-transgenic chickens. The results demonstrated that rhLZ-transgenic chicken 
could promote the growth of Bifidobacterium in the intestine and improve the postnatal growth of chicken.
Keywords: rhLZ, Transgenic chicken, Non-transgenic chicken, Bifidobacterium, Growth traits
© The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Introduction
Lysozyme (EC.3.2.1.17) widely exists in eukaryotes and 
prokaryotes to protect organism from microbial inva-
sion. Lysozyme functions by hydrolyzing β-1,4-glycosidic 
linkages between N-acetylglucosamine and N-acetyl-
muramic acid of the peptidoglycan layer in the bacterial 
cell wall (Chipman and Sharon 1969; Mai and Hu 2009). 
Lysozymes are generally classified into three major types: 
chicken type (c-type) (Kawamura et  al. 2012), goose 
type (g-type) (Simpson et al. 1980) and invertebrate type 
(i-type) (Ito et al. 1999). The c-type lysozyme exists ubiq-
uitously in many organisms including viruses, bacte-
ria, plants, insects, fishes, reptiles, birds, and mammals 
(Maga et al. 2006a; Jolles 1996). Human lysozyme (hLZ), 
one of c-type lysozymes, is a positively charged molecule 
that consists of a polypeptide of 130 amino acid resi-
dues (Booth et al. 1997; Yu et al. 2013). It is widely dis-
tributed in body fluids, such as tears, saliva, and blood 
and plays an important role in host defenses (Jolles and 
Jolles 1984). Lysozyme in human milk can be passed to 
infants through breast feeding, which helps to establish 
infants’ innate immune barrier (Ellison and Giehl 1991; 
Nascimento and Giugliano 2000). Likewise, human 
lysozyme has been shown to have antifungal and antivi-
ral activities (Kokoshis et al. 1978; Lee-Huang et al. 1999; 
Sava et al. 1988). Additionally, Lysozyme has a generally 
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recognized as safe (GRAS) status for use in the food 
industry, owing to its no toxic effects when taken at levels 
of 5 mg/g body weight (Osserman et al. 1973). Ultimately, 
hLZ seems promising in food industries and therapeutic 
applications.
As the human body only secretes limited natural hLZ, 
several transgenic animals have been utilized to produce 
bioactive recombinant human lysozyme (rhLZ), includ-
ing mice, goats, cows, and pigs (Cao et al. 2015; Lu et al. 
2015; Maga et al. 2006b; Tong et al. 2011; Yang et al. 2011; 
Yu et al. 2006). rhLZ in milk has been demonstrated that 
it not only contributes to the lactating animal but also 
benefits to intestinal morphology, and modulates intesti-
nal microbiota composition in infants to improve health 
of young animals (Brundige et al. 2008). In addition, rhLZ 
originated from transgenic animal milk is also of similar 
bioactivity as natural rhLZ (Liu et  al. 2012), indicating 
that rhLZ expressed in animal production may replace 
natural hLZ in the future.
However, up to now, the expression of functional rhLZ 
in poultry is still rarely available. Therefore, producing 
rhLZ in egg white will effectively reduce the cost and pre-
sent a promising application prospect. In this study, we 
generated transgenic chickens highly expressing rhLZ in 
egg white. The rhLZ exhibited similar physicochemical 
properties as natural hLZ, which revealed the potential of 
chicken eggs for hLZ producing.
Materials and methods
Construction of eukaryotic expression vector pHmLZ‑IRES2 
‑EGFP and pChLZ‑IRES2‑EGFP
Human lysozyme fragment (accession number M19045) 
containing chicken signal peptide with BamHI enzyme 
loci at 5 ‘end and XhoI enzyme loci at 3′ end was ampli-
fied from plasmid pGEM-T-HmLZ (gift from Prof Li 
Ning) using primers hLZ-F and hLZ-R (Table  1). The 
chicken lysozyme gene was amplified from cDNA of 
dwarf chicken (accession number X61198) using the 
primers ChLZ-F and ChLZ-R (Table  1). The two PCR 
products of human and chicken lysozyme fragments 
were ligated with pIRES2-EGFP (Sangon Biotech) after 
digested by XhoI and BamHI, respectively, at the propor-
tion of 3:1 under 16 °C over night. The recombinant vec-
tors were transformed into DH5α competent cells.
Transfection of 293FT cells with recombinant eukaryotic 
expression vectors
The approach of calcium phosphate transfection was 
used to transfect two recombinant expression vectors 
above and empty vector pIRES2-EGFP (1  μg/1μL) into 
293FT cell (laboratory storage). Briefly, four transfection 
groups were designed: Control group: 293FT cells with-
out transfection; Yp group: 293FT cells transfected with 
pIRES2-EGFP; Yh group: 293FT cells transfected with 
pHmLZ-IRES2 -EGFP; Yc group: 293FT cells transfected 
with pChLZ-IRES2-EGFP. 293FT cells were cultured in 
DMEM with 10% FBS at 5% CO2, saturated humidity, 
at 37 °C. Cells were transfected with four vectors above, 
respectively when cells reached 60–70% confluence. In 
order to detect transfection efficiency and expression of 
lysozyme, 293FT cells were collected at 48 h post trans-
fection, and RNA was extracted for subsequent cDNA 
synthesis and fluorescence quantitative PCR using the 
primers LYZ-F, LYZ-R; EGFP-F, EGFP-R and ACTIN-F, 
ACTIN-R (Table  1). The expression level of EGFP was 
relative to ACTIN which acted as the reference gene.
Antibacterial activity of 293FT cell supernatant
Since human and chicken lysozymes were secreted pro-
teins, we detected antibacterial activity of human and 
chicken lysozyme against Micrococcus  lysodeikticus 
ATCC no. 4698 (Sigma, S. Louis, MO, USA). A modifica-
tion of Shugar’s turbidimetric method was used. Firstly, 
a standard calibration curve was generated with puri-
fied chicken egg lysozyme as follows: Lysozyme (0.01 g) 
was added into 1  mL PBS solution (pH 6.5), and then 
diluted 100 times to ensure lysozyme concentration up 
to 100 μg/mL. Six of twofold serial dilutions (3.12, 6.25, 
12.5, 25, 50, 100 μg/mL) of lysozyme solution was made. 
The antibacterial activity of lysozyme in supernatant of 
293FT cells was determined by suppression of lysozyme 
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on Micrococcus lysodeikticus. Briefly, 5 mL of fresh Mic-
rococcus  lysodeikticus was centrifuged at 11,000g for 
5 min, the supernatant was discarded and the pellet was 
washed twice with 50  mM sodium phosphate (pH 8.0). 
The initial measurement value was adjusted to OD = 0.5, 
either by adding more bacteria or buffer. The assay was 
started by the addition of supernatant of 293FT cells and 
the lysozyme absorbance was recorded every 30  s over 
20 min using a spectrophotometer. One enzyme unit of 
enzyme activity corresponded to a decrease of 0.001 OD 
units each minute.
Construction of lentivirus expression vector 
pLL3.7‑HmLZ‑IRES2‑EGFP
HmLZ-IRES2-EGFP fragment with NheI enzyme loci 
at 5 ‘end and EcoRI enzyme loci at 3′ end was ampli-
fied from the recombinant eukaryotic expression vector 
pHmLZ-IRES2-EGFP using primers LYZ-F1 and LYZ-
R1 (Table  1). PCR products were recycled and digested 
by NheI and EcoRI together with plasmid pLL3.7, then 
ligated at the proportion of 10:1 blending 16  °C for the 
night and transformed into DH5α competent cells. 
Recombinant plasmid pLL3.7-HmLZ-IRES2-EGFP posi-
tive clones were sequenced.
Preparation and identification of transgenic chicken 
expressing rhLZ
Cell number of 293FT cells was adjusted to 1  ×  105/
well and added to 24-well plates. Virus was centrifuged 
at 3000 rpm for 5 min, and then supernatant was added 
to the 293FT cells at a concentration of 1/100 or 1/10. 
Green fluorescent protein could be observed after 72 h. 
Virus titers was determined using the UltraRapid Lentivi-
ral Titer Kit (System Biosciences, Mountain View, USA). 
1 μL virus suspension at a virus titer of 1 ×  106 IU/mL 
was microinjected into the central part of the subgermi-
nal cavity below the developing embryos of freshly laid 
eggs (stage-X) from dwarf chickens (Byun et  al. 2013), 
then supplemented with suitable amount of egg white, 
sealed with paraffin wax and hatched normally.
PCR amplification was performed with 3  weeks old 
offspring using primers I-F1, I-R1 and C-F1, C-R1 
(Table  1). Then Southern blot was used to identify the 
gene insertion. Briefly, about 20 μg DNA from chickens 
that PCR amplified positive were digested by Hind III, 
and conducted slow electrophoresis under a low voltage 
about 40  V for 12  h. Southern blot analysis was imple-
mented with specific hybridization probes which had 
been labelled with digoxigenin (DIG) using the PCR DIG 
Probe Synthesis Kit (Roche) after target fragments trans-
ferred to a Hybond-N membrane (Amersham Pharmacia 
Biotech, Piscataway, USA). Hybridization probes were 
amplified using the primers hLZ-S and hLZ-A (Table 1).
rhLZ expression of transgenic chickens
An enzyme-linked immunosorbent assay (ELISA) was 
performed to monitor human lysozyme expression of 
transgenic chickens. Briefly, 10  μL serum of periph-
eral blood from positive rhLZ transgenic chickens of 
20 weeks old was mixed with 990 μL sample diluent, then 
100  μL mixed liquor was added to 96-well plate astest 
group, meanwhile, some wells were only added 100  μL 
sample diluent as control group, and 100  μL standard 
sample was added to other wells as standard group. Then 
a competitive inhibition reaction was launched between 
HRP labeled human lysozyme and unlabeled human 
lysozyme (standards or samples) with the pre-coated 
antibody specific for human lysozyme. OD450 absorbance 
was measured by microplate reader to calculate the sam-
ple concentration. ELISA kit could simultaneously detect 
the recombinant or natural lysozyme with no cross reac-
tion with other related proteins.
Antimicrobial property of rhLZ in egg white
Lysoplate assay was performed. Briefly, 1% agar plate 
containing 1 × 108 CFU/mL of Micrococcus lysodeikticus 
sodium acetate buffer (0.1  M; pH 6.0) was prepared in 
petri dishes (approximately 5 mL per plate). When agar 
was solidified, wells were punched with the top of sterile 
pipette tips. Plates were refrigerated until use. A total of 
20 μL PBS was added into each well as negative control, 
blank control was also set. Crude exact of egg white was 
dissolved in PBS and 20 μL was added to the wells of agar 
plate containing Micrococcus lysodeikticus. At last, the 
plates were incubated at 37 °C for 24 h and observed for 
bacterial growth or bacterial clearance.
Phagocytic ability of monocyte from transgenic chickens
Monocyte plays an important role in both nonspecific 
and specific immune response, protecting the body from 
attacking by pathogenic microorganisms. In this study, a 
quick method (HCT8-MTT) was used to detect phago-
cytosis of monocyte/macrophage isolated from periph-
eral blood of fifteen individuals of transgenic chickens 
and non-transgenic chickens at the age of 90  days post 
hatch. Tumor cells treated by MTT were added to the 
mononuclear macrophage culture system, and then the 
ratio of OD570 of tumor cells swallowed and adhered to 
control cells was defined as phagocytosis product.
Distribution of microbial flora in feces between transgenic 
and non‑transgenic chickens
About 1 g fresh feces were collected in the sterile tubes 
weighed in advance from fifteen individuals of trans-
genic chickens and non-transgenic chickens at the age 
of 35  weeks post-hatch respectively, and then put into 
the anaerobic tank immediately, followed with bacteria 
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isolation and culture. Finally, the number of Lactobacil-
lus, Salmonella, Bifidobacterium, Staphylococcus aureus 
and Escherichia coli was detected.
Detection of growth performance between transgenic 
and non‑transgenic chickens
Transgenic chickens and non-transgenic chickens were 
raised in the same chamber with commercial feed ad libi-
tum. Growth traits including birth weight, 6-week shank 
length, 6-week weight, 18-week weight of transgenic and 
non-transgenic chickens were recorded and analyzed.
Statistical analysis
Data are shown as mean  ±  SEM (lysozyme assay). All 
data was analyzed by a one-way Analysis of Variance 
(ANOVA) followed by Tukey’s post hoc test (software: 
SPSS 16.0 for Windows, SPSS Inc., USA).
Results
Transfection efficiency of eukaryotic expression vectors 
and expression of EGFP in transfected 293FT cells
Eukaryotic expression vectors pChLZ-IRES2-EGFP and 
pHmLZ-IRES2-EGFP were constructed (Fig.  1). 293FT 
cells transfected with pChLZ-IRES2-EGFP showed highest 
expression of green fluorescent protein at 48 h post trans-
fection (Fig. 2a, b), 293FT cells transfected with pHmLZ-
IRES2-EGFP showed medium expression (Fig. 2c, d), and 
293FT cells transfected with pIRES2-EGFP showed low 
expression (data not shown). Results showed that it was 
proportional to cell transfection efficiency.
Gel electrophoresis showed that lysozyme was 
expressed in both 293FT cells transfected with pHmLZ-
IRES2-EGFP and pChLZ-IRES2-EGFP. The 293FT cells 
transfected with pIRES2-EGFP appeared no expression 
of lysozyme; Green fluorescent protein did not express 
in control group (Fig. 3a). In addition, Quantitative PCR 
results showed that expression of EGFP in Yp, Yc and 
Yh group was 3.6, 21.3, and 5.4, respectively (Fig.  3b). 
Expression of green fluorescent protein in group Yc was 
four times of that of group Yh; therefore, transfection 
efficiency of group Yc was four times of group Yh. Since 
expression of proteins on both sides of IRES2 regulatory 
elements was the same, then we could speculate that 
amount of chicken lysozyme expression was four times of 
human lysozyme after 48 h transfection.
Detection of antibacterial activity in supernatant of 293FT 
cells
Compared to the control group, Yp group represented 
no significant difference in antibacterial activity against 
Micrococcus lysodeikticus. Both of them showed no obvi-
ous antibacterial effect (Fig. 3d). Yc and Yh group showed 
stronger antibacterial activity than Yp group (P  <  0.01). 
Yh group showed stronger antibacterial activity than 
Yc group (P  <  0.05). In addition, average enzyme activ-
ity of egg white lysozyme was 54 U in Yc group, 79 U in 
Yh group. Antibacterial activity against Micrococcus lyso-
deikticus of recombinant human lysozyme was about six 
times than that of chicken lysozyme.
Observation of EGFP in 293FT cells infected with lentivirus
The expression of green fluorescent protein in 293FT 
cells infected with lentivirus could be observed under 
microscope at 72  h post transfection (Fig.  4). As calcu-
lated, virus titer was 1 × 106 TU/mL.
Identification of transgenic chickens
The lentivirus expression vector pLL3.7-HMLZ-IRES2-
EGFP (Fig. 1) was constructed and used to prepare trans-
genic chickens. DNA from peripheral blood of transgenic 
chickens was amplified, followed with detection of South-
ern blot. 649  bp PCR products and 287  bp PCR prod-
ucts were obtained indicating that human lysozyme gene 
might have been integrated into chicken genome (Fig. 5a). 
Totally, 194 transgenic chickens were identified by South-
ern blot with a positive transgenic rate of 24% (Fig. 5b).
Detection of rhLZ expression of transgenic chickens
OD450 of transgenic chicken, wild chicken and stand-
ard samples were read. According to the formula of 
y  =  −0.023  ×  −0.024(R2  =  0.994) (Fig.  5c), we could 
calculate the concentration of lysozyme in serum. 
Lysozyme concentration of six transgenic chickens was 
32.9, 32.0, 43.7, 41.8, 29.9, and 27.9 μg/mL, respectively. 
The lysozyme for two non-transgenic chickens was 2.8 
and 2.7  μg/mL, respectively. Average lysozyme concen-
tration of transgenic chicken was 29.9  μg/mL (Fig.  5d). 
Since similar structure between human and chicken 
lysozyme, they couldn’t be detected separately. The con-
centration here was combination of human and chicken 
lysozyme. It is obvious that lysozyme concentration 
in serum of transgenic chicken was ten times of those 
non-transgenic.
Antimicrobial property of rhLZ in egg white tested by agar 
diffusion test
Egg white of transgenic chickens named 102,103 and 105 
were collected. Simultaneously, egg white of age-matched 
non-transgenic chicken named NT was also gathered. 
After adsorbing of different sample filters, solid medium 
would appear bacterial plaques of different sizes, with no 
plaques presenting in blank. Antibacterial activity was 
measured by the size of bacteriostatic circle. The results 
showed that transgenic chickens expressed significantly 
higher antimicrobial property than that of non-trans-
genic chickens (P < 0.05) (Fig. 6).
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Phagocytic ability of monocyte from transgenic 
and non‑transgenic chickens
It was showed that the phagocytosis products were 
between 1.5 and 3.0 (Fig.  7), and normally distributed. 
Compared with non-transgenic chickens, monocyte 
phagocytosis of transgenic chickens tended a bit stronger 
and did a same population trend.
Difference of microbiota in feces between transgenic 
chickens and non‑transgenic chickens
Five types of bacteria were separated and cultured to 
analyze the impact of rhLZ on gut microbiota. The num-
ber of Bifidobacterium in the feces of transgenic chick-
ens was significantly increased (4.83 × 107 ± 0.66 × 106 
CFU vs 1.46  ×  107  ±  0.13  ×  106 CFU, P  <  0.05). The 
number of Staphylococcus aureus, Escherich.coli, Salmo-
nella, and Lactobacillus appeared no significant differ-
ence (Fig. 8).
Analysis of growth performance of transgenic chickens 
and non‑transgenic chickens
Growth traits of transgenic chickens (100 individuals) 
and non-transgenic chickens (100 individuals) were col-
lected. It was found that the 6-week shank length, 6-week 
weight and 18-week weight of those transgenic were sig-
nificantly increased (Fig. 9).
Discussion
As lentiviral vector can carry large exogenous gene 
(~8  kb) and integrate these genes into the genomes of 
both dividing and non-dividing cells, it is considered to 
be an ideal candidate for transporting genetic material 
into cells and tissues (Harvey et  al. 2002a, b; McGrew 
et al. 2004; Sang 1994; Semple-Rowland and Berry 2014). 
Lentiviral vector systems have been considered to be 
the most successful method for generating transgenic 
chickens through delivering genes to embryos in newly 
Fig. 1 Schematic diagram for eukaryotic expression vectors pChLZ-IRES2-EGFP and pHmLZ-IRES2-EGFP and lentivirus expression vector pLL3.7-
HmLZ-IRES2-EGFP
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laid eggs (Byun et al. 2013; Kwon et al. 2004; Lillico et al. 
2007). The stable transmission of the integrated vector 
through the germ line was demonstrated with conserved 
expression of exogenous gene in the G1 and G2 genera-
tions (Byun et al. 2011).
Due to its inherent antimicrobial activity, human 
lysozyme (hLZ) in egg white has the potential to improve 
the nutritional value and antibacterial activity of egg. 
Researchers reported that hLZ expressed in the mam-
mary gland in transgenic mice enhanced the antimicro-
bial properties of milk (Maga et  al. 1998). hLZ is more 
bioactive than its avian counterparts (White et al. 1988), 
thereby adding hLZ to chicken via genetic engineering 
will help to increase the levels of endogenous lysozyme. 
Consistent to these findings, we found that egg white 
of transgenic chickens exhibited a stronger antibacte-
rial activity by agar diffusion test in this study. Reports 
showed that phagocytosis of monocytes-macrophages 
was a marker for disease resistance of dwarf chickens 
(Ma et  al. 2010). In this study, monocytes-macrophages 
phagocytosis of transgenic chickens tended a bit stronger 
than non-transgenic chickens, which probably indicated 
that hLZ could strengthen chickens, disease resistance. 
hLZ is normally present in the tears, saliva, and egg 
white of chicken without causing any allergic response 
when consumed by humans or animals. However, it usu-
ally brings about a problem that rhLZ may be expressed 
in a form of inclusion, only exhibiting its activity after 
refolded. In this study, results of the Elisa analysis showed 
that transgenic chickens expressing rhLZ using a lenti-
viral vector system was successful. Moreover, previous 
research revealed that rhLZ overexpression in rabbit 
caused a lactation problem (Houdebine 2009); however, 
there were no difficulties in producing the next genera-
tion of these transgenic chickens.
Considering the impact factors that lentiviral vec-
tor systems can deliver exogenous DNA fragments of 
approximately 8 kb, viral titers are inversely proportional 
to the size of inserted fragments and virus packaging effi-
ciency, a maximum size of the 5′-regulatory region of the 
CMV gene that can be packaged into virus particles was 
selected. Finally, the plasmid pLL3.7-HmLZ-IRES2-EGFP 
composed of the CMV promoter of 553  bp and hLZ 
gene of 447 bp was constructed and used to produce the 
recombinant virus particles.
In order to realize rhLZ secreted into chicken cells, 
human lysozyme signal peptide was replaced by chicken 
lysozyme signal peptide. It was confirmed that chicken 
Fig. 2 The transient expression result of vectors in 293FT cell line. a and b Represent the transient expression of pIRES2-HMLZ-EGFP in 293FT cell 
line (×100). c and d Represent the transient expression of pIRES2-CHLZ-EGFP in 293FT cell line (×100). Besides, a and c showed the fluorescent 
background, while b and d showed the EGFP observation
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signal peptide could direct rhLZ secretion into chickens. 
In this study, we obtained transgenic chickens express-
ing bioactive human lysozyme to an amount of 29.9 μg/
mL with excluded gene silence and inhibition that usu-
ally happen in transgenic chickens prepared by lentivi-
ral vector (Mizuarai et al. 2001). The expression levels of 
rhLZ were different among individuals, probably result-
ing from position effects caused by chromosomal loca-
tion of the transgene insertion (Dobie et  al. 1996; Kong 
et al. 2009; Robertson et al. 1995). Therefore, selecting of 
transgenic chickens expressing rhLZ of high levels will be 
available for commercial production.
Fig. 3 Relative expression of EGFP in transfected 293FT cells and antibacterial activity of supernatant of 293FT cells. a PCR amplification of lysozyme 
and EGFP in transfected 293FT cells. Lane 1, 2, 3, and 4 shows expression of lysozyme and EGFP in Yp group, Yh group, Yc group and control group, 
respectively. b qPCR detection of EGFP expression in transfected 293FT cells. c Standard curve of lysozyme activity. d Antibacterial activity against 
micrococcus lysodeikticus of supernatant of 293FT cell. Control group: 293FT cells without transfection; Yp group: 293FT cells transfected with 
pIRES2-EGFP; Yh group: 293FT cells transfected with pHmLZ-IRES2-EGFP; Yc group: 293FT cells transfected with pChLZ-IRES2-EGFP. Statistical signifi-
cance is presented as follows: *P < 0.05; **P < 0.01
Fig. 4 The expression of EGFP in 293FT cells at 72 h post infection (100X). a Represents the fluorescent background; b represents EGFP observation
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In feeding trials using animal models, pasteurized 
milk from HLZ transgenic animals was capable of 
modulating microbial growth in the intestine (Maga 
et al. 2006c). Lysozyme is thought to help contribute to 
a healthier gastrointestinal tract (Goldman 2007; Lon-
nerdal 2003). So we detect the intestine flora of both 
Fig. 5 Preparation, identification and rhLZ expression of transgenic chickens a PCR amplification of the exogenous rhLZ in transgenic chicken, sam-
ples from lane 1 to lane 5, lane P (positive plasmid) and lane N (negative control) were listed; b Detection of rhLZ in transgenic chickens by Southern 
blot. Samples from lane 2 to lane 8 showed for the positive transgenic chickens, while sample of lane 1 represented non-transgenic chicken. c Stand-
ard curve of rhLZ expressed in the serum. d Concentration of rhLZ in the serum of both transgenic and non-transgenic chickens
Fig. 6 Antimicrobial property of rhLZ in egg white tested by agar diffusion test. a The inhibition zone square of the transgenic chickens and non-
transgenic chickens. b Diagrammatic sketch of the agar diffusion test for the transgenic group and non-transgenic group. Individuals of 102,103 and 
105 represented transgenic chickens, NT represented non-transgenic chicken; B represented blank
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transgenic chickens and non-transgenic chickens by 
analyzing their feces collected. In our study, the number 
of Bifidobacteria of those transgenic was significantly 
higher than those non-transgenic indicating that rhLZ 
promotes Bifidobacteria proliferation. Bifidobacteria, 
normal habitants of the intestinal tract amounts to 1010 
CFU/g of intestinal contents (Tannock 1995). These 
bacteria exhibit several healthy, nutritional and thera-
peutic benefits to hosts including reduction of blood 
cholesterol (Modler 1994), improvement of lactose 
utilization in malabsorbers (Tianan Jiang Amad 1996), 
and increased immunity in animal hosts (Ali 2009; Gill 
1998). They are believed to be essential for maintaining 
the healthy equilibrium between beneficial and poten-
tially harmful microorganisms in the gastrointestinal 
tract (Sreekumar and Hosono 1998). In terms of clini-
cal reports, Bifidobacteria tend to reduce the incidence 
of rotaviral infection, traveller’s diarrhea and antibiotic 
associated diarrhea (Zuccotti et al. 2008). They also have 
effects on pathogens belonging to the genera Salmo-
nella, Escherichia, Proteus, Shigellaand Candida (Dicks 
and Botes 2010). Although, lysozymes are reportedly 
more effective against gram-positive bacteria lacking 
the outer membrane found in gram-negative bacteria 
(Costerton et  al. 1974). Surprisingly, Bifidobacterium 
appeared to be more resistant than other Gram positive 
bacteria and Gram negative bacteria to lysozyme in the 
current study.
Additionally, we found that transgenic chickens showed 
significantly high growth performance than non-trans-
genic chickens, but of similar hatching rate and healthy 
chick rate (data not shown). It might indicate that rhLZ 
did not affect hatch and health of chickens. Furthermore, 
exogenous gene, rhLZ, improved the growth of postna-
tal chickens by modulating their intestine flora structure 
thereby promoting intestine immune and facilitating 
chicken growth and development.
With the result that Bifidobacteria appear increased in 
recombinant human lysozyme transgenic chickens and 
these transgenic chickens gained more weight at post-
natal, Interest comes that whether Bifidobacteria has a 
direct or indirect correlation with lysozyme.
In conclusion, we demonstrate that lentivirus-medi-
ated expression of recombinant human lysozyme in 
transgenic chickens is feasible. The lysozyme concentra-
tion is much higher in transgenic chicken than that in 
non-transgenic chicken, which indicated that albumen 
from transgenic chicken showed a higher antibacterial 
Fig. 7 Phagocytic ability of monocyte from transgenic chickens and 
non-transgenic chickens. X axis represents phagocytosis product; Y 
axis represents percentage of transgenic chickens and non-trans-
genic chickens
Fig. 8 Distribution of Lactobacillus, Bifidobacterium, Staphylococ-
cus aureus, Escherich.coli and Salmonella in the feces of transgenic 
chickens and non-transgenic chickens. An asterisk [*] marked in graph 
indicates statistical significance
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activity. rhLZ-transgenic chicken promote Bifidobac-
teria proliferation and improve the growth of postnatal 
chicken.
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